Vertex Pharmaceuticals Inc. (VRTX) News Nov 20, 20
Post# of 250674
Posted On: 11/21/2014 12:17:23 AM
Vertex Pharmaceuticals Inc. (VRTX) News Nov 20, 2014, 5:32 p.m.
MarketWatch News on VRTX
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Twitter gives out 47% of its revenue in stock bonuses 12:51 p.m. Oct. 29, 2014 - Philip van Doorn
11 stocks rising the most as the market heads toward a correction 10:29 a.m. Oct. 15, 2014 - Philip van Doorn
Everything you need to know about investing you learned in grade school 2:09 p.m. Oct. 7, 2014 - Tomi Kilgore
S&P, Nasdaq violate major support 9:02 a.m. Oct. 1, 2014 - Michael Ashbaugh
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
Oracle falls on earnings, Ellison move; Alibaba soars on debut 3:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 8:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 2:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 12:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 12:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 10:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 3:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 2:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 2:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 12:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 8:33 a.m. June 24, 2014 - Sue Chang
Vertex’ late-stage Cystic Fibrosis trial meets goals 6:59 a.m. June 24, 2014 - Anna Prior
Other News on VRTX
Insider Trading Alert - LNKD, VRTX And RLGY Traded By Insiders 11:31 a.m. Nov. 20, 2014 - TheStreet.com
CF Foundation sells royalties for $3.3B 8:03 a.m. Nov. 20, 2014 - Seeking Alpha
Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma 1:25 p.m. Nov. 19, 2014 - TheStreet.com
Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma 1:25 p.m. Nov. 19, 2014 - TheStreet.com
Cystic Fibrosis Foundation Sells Drug’s Rights for $3.3 Billion 1:13 p.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
Barbarian At The Gate: Vertex Pharmaceuticals (VRTX) 12:21 p.m. Nov. 19, 2014 - TheStreet.com
3 Drugs Stocks Driving The Industry Higher 12:16 p.m. Nov. 19, 2014 - TheStreet.com
Stock Market News for November 17, 2014 - Market News 10:10 a.m. Nov. 17, 2014 - Zacks.com
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog 8:48 a.m. Nov. 12, 2014 - Zacks.com
Are Expensive Biotech Drugs Bad For Business? 10:45 a.m. Nov. 11, 2014 - Seeking Alpha
Stock Market News for November 11, 2014 - Market News 10:10 a.m. Nov. 11, 2014 - Zacks.com
Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex ... 2:20 p.m. Nov. 9, 2014 - GuruFocus.com
Market Rally Brings Out Insider Sellers in Full Force 8:37 a.m. Nov. 8, 2014 - 247WallSt.com
Vertex Pharmaceuticals Seeks Approval for CF Combination - Analyst Blog 6:25 p.m. Nov. 6, 2014 - Zacks.com
10-Q: VERTEX PHARMACEUTICALS INC / MA 4:05 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
3 Stocks Moving The Drugs Industry Upward 12:05 p.m. Nov. 6, 2014 - TheStreet.com
Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on Lifting of Clinical Hold - Analyst Blog 9:46 a.m. Nov. 5, 2014 - Zacks.com
Vertex files marketing apps for CF combo 7:55 a.m. Nov. 5, 2014 - Seeking Alpha
Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 30, 2014 - Zacks.com
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog 1:00 p.m. Oct. 29, 2014 - Zacks.com
Press Releases on VRTX
Vertex to Present at Deutsche Bank BioFEST on December 2 4:02 p.m. Nov. 20, 2014 - BusinessWire - BZX
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF 9:03 a.m. Nov. 19, 2014 - PR Newswire - PRF
Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation 7:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
Vertex to Present at the Credit Suisse Healthcare Conference on November 11 3:04 p.m. Oct. 30, 2014 - BusinessWire - BZX
Arrival of Former FDA Senior Officials Accelerates Greenleaf Expansion 7:00 a.m. Oct. 29, 2014 - BusinessWire - BZX
Vertex Reports Third Quarter 2014 Financial Results 3:04 p.m. Oct. 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:47 p.m. Oct. 21, 2014 - BusinessWire - BZX
Vertex to Announce Third Quarter 2014 Financial Results on October 28 3:01 p.m. Oct. 14, 2014 - BusinessWire - BZX
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis 8:32 a.m. Oct. 9, 2014 - BusinessWire - BZX
Senior Housing Properties Trust Announces LEED® Gold Certification of the Vertex Pharmaceuticals Biotech Buildings 7:02 a.m. Oct. 8, 2014 - BusinessWire - BZX
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 8:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 8:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 8:03 a.m. Sept. 8, 2014 - BusinessWire - BZX
Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10 3:02 p.m. Sept. 2, 2014 - BusinessWire - BZX
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 7:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 8:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 1:45 p.m. Aug. 11, 2014 - ACCESSWIRE
MarketWatch News on VRTX
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Twitter gives out 47% of its revenue in stock bonuses 12:51 p.m. Oct. 29, 2014 - Philip van Doorn
11 stocks rising the most as the market heads toward a correction 10:29 a.m. Oct. 15, 2014 - Philip van Doorn
Everything you need to know about investing you learned in grade school 2:09 p.m. Oct. 7, 2014 - Tomi Kilgore
S&P, Nasdaq violate major support 9:02 a.m. Oct. 1, 2014 - Michael Ashbaugh
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
Oracle falls on earnings, Ellison move; Alibaba soars on debut 3:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 8:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 2:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 12:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 12:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 10:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 3:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 2:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 2:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 12:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 8:33 a.m. June 24, 2014 - Sue Chang
Vertex’ late-stage Cystic Fibrosis trial meets goals 6:59 a.m. June 24, 2014 - Anna Prior
Other News on VRTX
Insider Trading Alert - LNKD, VRTX And RLGY Traded By Insiders 11:31 a.m. Nov. 20, 2014 - TheStreet.com
CF Foundation sells royalties for $3.3B 8:03 a.m. Nov. 20, 2014 - Seeking Alpha
Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma 1:25 p.m. Nov. 19, 2014 - TheStreet.com
Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma 1:25 p.m. Nov. 19, 2014 - TheStreet.com
Cystic Fibrosis Foundation Sells Drug’s Rights for $3.3 Billion 1:13 p.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
Barbarian At The Gate: Vertex Pharmaceuticals (VRTX) 12:21 p.m. Nov. 19, 2014 - TheStreet.com
3 Drugs Stocks Driving The Industry Higher 12:16 p.m. Nov. 19, 2014 - TheStreet.com
Stock Market News for November 17, 2014 - Market News 10:10 a.m. Nov. 17, 2014 - Zacks.com
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog 8:48 a.m. Nov. 12, 2014 - Zacks.com
Are Expensive Biotech Drugs Bad For Business? 10:45 a.m. Nov. 11, 2014 - Seeking Alpha
Stock Market News for November 11, 2014 - Market News 10:10 a.m. Nov. 11, 2014 - Zacks.com
Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex ... 2:20 p.m. Nov. 9, 2014 - GuruFocus.com
Market Rally Brings Out Insider Sellers in Full Force 8:37 a.m. Nov. 8, 2014 - 247WallSt.com
Vertex Pharmaceuticals Seeks Approval for CF Combination - Analyst Blog 6:25 p.m. Nov. 6, 2014 - Zacks.com
10-Q: VERTEX PHARMACEUTICALS INC / MA 4:05 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
3 Stocks Moving The Drugs Industry Upward 12:05 p.m. Nov. 6, 2014 - TheStreet.com
Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on Lifting of Clinical Hold - Analyst Blog 9:46 a.m. Nov. 5, 2014 - Zacks.com
Vertex files marketing apps for CF combo 7:55 a.m. Nov. 5, 2014 - Seeking Alpha
Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 30, 2014 - Zacks.com
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog 1:00 p.m. Oct. 29, 2014 - Zacks.com
Press Releases on VRTX
Vertex to Present at Deutsche Bank BioFEST on December 2 4:02 p.m. Nov. 20, 2014 - BusinessWire - BZX
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF 9:03 a.m. Nov. 19, 2014 - PR Newswire - PRF
Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation 7:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
Vertex to Present at the Credit Suisse Healthcare Conference on November 11 3:04 p.m. Oct. 30, 2014 - BusinessWire - BZX
Arrival of Former FDA Senior Officials Accelerates Greenleaf Expansion 7:00 a.m. Oct. 29, 2014 - BusinessWire - BZX
Vertex Reports Third Quarter 2014 Financial Results 3:04 p.m. Oct. 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:47 p.m. Oct. 21, 2014 - BusinessWire - BZX
Vertex to Announce Third Quarter 2014 Financial Results on October 28 3:01 p.m. Oct. 14, 2014 - BusinessWire - BZX
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis 8:32 a.m. Oct. 9, 2014 - BusinessWire - BZX
Senior Housing Properties Trust Announces LEED® Gold Certification of the Vertex Pharmaceuticals Biotech Buildings 7:02 a.m. Oct. 8, 2014 - BusinessWire - BZX
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 8:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 8:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 8:03 a.m. Sept. 8, 2014 - BusinessWire - BZX
Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10 3:02 p.m. Sept. 2, 2014 - BusinessWire - BZX
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 7:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 8:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 1:45 p.m. Aug. 11, 2014 - ACCESSWIRE
(0)
(0)